Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
12.33
+0.36 (3.01%)
At close: Aug 13, 2026, 4:00 PM EDT
11.87
-0.46 (-3.73%)
Pre-market: Aug 14, 2026, 4:01 AM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $4.01 billion as of August 13, 2026. Its market cap has increased by 8.81% in one year.
Market Cap
4.01B
Enterprise Value
4.36B
1-Year Change
8.81%
Ranking
Category
Stock Price
$12.33
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $4.01B, an increase of 3,381.54%. That is a compound annual growth rate of 50.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 4.17B | 64.93% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.56B |
| Celcuity | 4.49B |
| Relay Therapeutics | 4.40B |
| Tango Therapeutics | 4.31B |
| Enliven Therapeutics | 4.24B |
| Denali Therapeutics | 4.04B |
| Legend Biotech | 3.99B |
| Viking Therapeutics | 3.97B |